Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
In the clinical trial, the 8mg group showed 22.8% average weight loss, which is still higher than any other weight loss medication at its maximum dose
Ozempic is one of many drugs classed as GLP-1 receptor agonists
Li, Y., Wang, S
A phase 2, double-blind, placebo-controlled trial randomized patients with moderate-severe PDPN to subcutaneous fulranumab or placebo
Given the first-mover commercial advantages documented in biosimilar markets (the first two to three entrants have consistently captured over 90% of biosimilar market share in physician-administered settings), the race-to-market analysis is as commercially important as the patent litigation analysis
US$ 21.51
US$ 29.90
US$ 28.87
US$ 20.49
US$ 23.58
US$ 24.04
US$ 23.60
US$ 22.24
US$ 29.29
US$ 26.50
US$ 25.40
